Action Newellis - NUWE

Newellis Inc (NUWE) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

3,0408

( -4,38% )

Prix Achat

3,02

Prix Vente

3,18

Volume échangé

124 530

2,88 Fourchette du Jour 3,18

0,0823 Plage de 52 semaines 25,95

Cap du marché

255,604k

Clôture Veille

3,18

Ouverture

3,13

Dernière Transaction

3.03

Dernière heure de transaction

Volume financier

US$ 377 811

VWAP

3,0339

Volume moyen (3 m)

US$ 66 020

Actions en circulation

84 058

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-0,2

Bénéfice par action (BPA)

-16,1

Chiffre d'affairess (LTM)

8,77M

Bénéfice net (LTM)

-19,05M

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as A... Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. Show more

Secteur

Healthcare

Industrie

Medical Equipment & Supplies

Site Web

www.nuwellis.com

Siège social

Eden Prairie, United States

Fondé

1999

Newellis Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker NUWE. Le dernier cours de clôture d'Newellis était de US$3,18. Au cours de la dernière année, les actions de Newellis ont été négociées dans une fourchette de prix de US$ 0,0823 à US$ 25,95.

Newellis compte actuellement 84 058 actions en circulation. La capitalisation boursière d'Newellis est de US$255 603,57 . Newellis a un ratio cours/bénéfice (ratio PE) de -0.20.

Form PRE 14A - Other preliminary proxy statements

Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)

MINNEAPOLIS, June 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company...

Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations

MINNEAPOLIS, June 25, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company...

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

MINNEAPOLIS, June 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company...

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company...

Nuwellis Appoints Mike McCormick as Chief Executive Officer

MINNEAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company...

Form 8-K - Current report

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals

MINNEAPOLIS, June 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company...

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

MINNEAPOLIS , June 08, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company...

Form 424B4 - Prospectus [Rule 424(b)(4)]

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	2.9148	2313.33333333	0.126	3.7999	0.0823	2960078	0.35687924	CS
4	2.3408	334.4	0.7	3.7999	0.0823	5558008	0.18856291	CS
12	1.9508	178.972477064	1.09	3.7999	0.0823	1877188	0.21125663	CS
26	1.2508	69.8770949721	1.79	4.9399	0.0823	1936658	2.09843436	CS
52	2.8174	1261.14592659	0.2234	25.95	0.0823	1240500	4.0983735	CS
156	0.2908	10.5745454545	2.75	25.95	0.0823	2207288	1.31319448	CS
260	-1.1292	-27.0791366906	4.17	25.95	0.0823	1899148	1.25498621	CS

NUWE - Frequently Asked Questions (FAQ)

What is the current Newellis Inc share price?

The current share price of Newellis Inc is US$ 3,0408

How many Newellis Inc shares are in issue?

Newellis Inc has 84 058 shares in issue

What is the market cap of Newellis Inc?

The market capitalisation of Newellis Inc is USD 255,6k

What is the 1 year trading range for Newellis Inc share price?

Newellis Inc has traded in the range of US$ 0,0823 to US$ 25,95 during the past year

What is the PE ratio of Newellis Inc?

The price to earnings ratio of Newellis Inc is -0,2

What is the cash to sales ratio of Newellis Inc?

The cash to sales ratio of Newellis Inc is 0,03

What is the registered address of Newellis Inc?

The registered address for Newellis Inc is 12988 Valley View Road, Eden Prairie, Minnesota, 55344

What is the Newellis Inc website address?

The website address for Newellis Inc is www.nuwellis.com

Which industry sector does Newellis Inc operate in?

Newellis Inc operates in the Medical Equipment & Supplies sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Newellis Inc (NUWE)

Newellis Inc (NUWE) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Newellis Inc

NUWE Dernières nouvelles

Form PRE 14A - Other preliminary proxy statements

Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)

Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

Nuwellis Appoints Mike McCormick as Chief Executive Officer

Form 8-K - Current report

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form PRE 14A - Other preliminary proxy statements

Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)

Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

Nuwellis Appoints Mike McCormick as Chief Executive Officer

Form 8-K - Current report

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals

NUWE - Frequently Asked Questions (FAQ)

NUWE Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités